The purpose of this project is to compare two pharmacist-led population management strategies designed to increase the rate of appropriate monitoring of vitamin B12 and serum creatinine for patients taking metformin.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Enrollment
489
Pharmacist communicates monitoring recommendations to physician through the electronic medical record prior to a scheduled patient office visit
Pharmacist communicates need for monitoring directly to patients and instructs them to obtain monitoring on their own time without need for an office visit with physician
The Ohio State University General Internal Medicine
Columbus, Ohio, United States
Percentage of patients in each arm who obtain monitoring of vitamin B12 as recommended
Time frame: 6 months
Number of patients with newly identified vitamin B12 deficiency
Time frame: 6 months
Percentage of patients with newly identified vitamin B12 deficiency who have prior evidence of anemia upon chart review
When a patient's serum vitamin B12 level comes back and is low the chart will be reviewed immediately to determine this. This could happen anytime during the 6 month study period.
Time frame: within 6 months
Percentage of patients with newly identified vitamin B12 deficiency who have prior evidence of neuropathy upon chart review
When a patient's serum vitamin B12 level comes back and is low the chart will be reviewed immediately to determine if neuropathy is also listed as a medical problem. This could happen anytime during the 6 month study period.
Time frame: within 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.